Healthcare Focus Montserrat: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Focus Montserrat.

Press releases published on November 6, 2026

3 hours ago

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

3 hours ago

Wegweisende Therapie bei fortgeschrittener Herzinsuffizienz: Der wissenschaftliche Mitgründer von Repairon, Prof. Wolfram-Hubertus Zimmermann, erhält den „Galenus-von-Pergamon“-Preis 2026 für herausragende pharmakologische Grundlagenforschung

Indeterminate GlobeNewswire

3 hours ago

Une approche thérapeutique innovante pour le traitement de l’insuffisance cardiaque avancée : le professeur Wolfram-Hubertus Zimmermann, cofondateur scientifique de Repairon, reçoit le prix « Galenus-von-Pergamon » 2026 pour ses travaux exceptionnels d…

Indeterminate GlobeNewswire

3 hours ago

Hengrui Pharma and Braveheart Bio Present Data from 52-Week Open-Label Extension of Phase 2 Study of HRS/BHB-1893 in Obstructive Hypertrophic Cardiomyopathy at American Heart Association Scientific Sessions 2026

Indeterminate GlobeNewswire

6 hours ago

Spectral Medical Inc. Announces Closing of Second Tranche of $14.0 Million Convertible Note Private Placement

Indeterminate GlobeNewswire

7 hours ago

Immunocore presents promising data from Phase 1/2 trial cohort evaluating brenetafusp plus KIMMTRAK® (tebentafusp-tebn) in metastatic uveal melanoma

Indeterminate GlobeNewswire

7 hours ago

Chemed Corporation Declares Quarterly Dividend of 70 Cents

Indeterminate GlobeNewswire

8 hours ago

New phase 2 data highlight the strength of the immune response induced by personalized cancer vaccine EVX-01

Indeterminate GlobeNewswire

8 hours ago

HCW Biologics’ Presentation for HCW11-040 Recognized for Scientific Rigor, Novelty, Clarity and Potential Impact on Cancer Immunotherapy by the Society for Immunotherapy of Cancer

Indeterminate GlobeNewswire

8 hours ago

KFSH Riyadh gewinnt Davos Healthcare Global Elite Five-Star Medallion und zählt zu den besten 5 % der bewerteten Krankenhäuser

Indeterminate GlobeNewswire

8 hours ago

Le KFSH de Riyad obtient la distinction « Global Elite Five-Star » de Davos Healthcare et figure parmi les 5 % des hôpitaux les mieux évalués au monde

Indeterminate GlobeNewswire

8 hours ago

TOMI Environmental Solutions, Inc. Reschedules Third Quarter 2026 Earnings Call to Thursday, November 12

Indeterminate GlobeNewswire

9 hours ago

MiNK Therapeutics New Data Highlights Its Off-the-Shelf iNKT Cell Therapy Targets Two Key Mechanisms of Tumor Resistance Presented at the Society of Immunotherapy of Cancer (SITC 2026)

Indeterminate GlobeNewswire

9 hours ago

AI in Virtual Medical Assistants Market to Worth USD 8.85 Billion by 2030, at a CAGR of 36.6%– MarketsandMarkets™

Indeterminate GlobeNewswire

9 hours ago

HCW Biologics Presents Newly Identified Distinctive Features of Its Lead T Cell Engager Candidate Built with Company’s Proprietary T-Cell Engager Platform, Further Supporting Its Use in Treating Solid Tumors at the Society for Immunotherapy of Cancer’s…

Indeterminate GlobeNewswire

10 hours ago

Immunocore reports third quarter financial results and provides a business update

Indeterminate GlobeNewswire

10 hours ago

Candel Therapeutics Presents SITC 2026 Data Highlighting Systemic Immune Activation and Survival Outcomes Across Clinical-Stage Portfolio

Indeterminate GlobeNewswire

10 hours ago

Compass Therapeutics Presents Novel Mechanism of Action Data for CTX-10726 (PD-1 x VEGF-A Bispecific Antibody) at the SITC 2026 Annual Meeting

Indeterminate GlobeNewswire

10 hours ago

SOTIO Presents Initial Data from VICTORIA-01 Phase 1 Clinical Study of Immunocytokine SOT201 at SITC Annual Meeting

Indeterminate GlobeNewswire

10 hours ago

Atebimetinib Combinations with Anti-PD1 Cured 50% of Mice in a RAS-Mutant Colorectal Cancer Model and Nearly Doubled Survival in a RAS-Mutant Lung Cancer Model; New Data Presented at SITC 2026

Indeterminate GlobeNewswire